Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jacob Painter

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPharmacy Practice, College of Pharmacy
DivisionPharmacy Practice
Address6257 ED III College of Public Health
220 UAMS Campus Dr.
Mail Slot # 522
Little Rock AR 72205
Phone501-686-7123
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentPsychiatry, College of Medicine
    DivisionCenter for Health Service Research


    Collapse Research 
    Collapse research activities and funding
    R01NR019487     (FELIX, HOLLY)Jul 1, 2023 - Jun 30, 2025
    NIH/Nat. Inst. of Nursing Research
    Home Food Delivery for Diabetes Management in Patients of Rural Clinics - Continuation
    Role: Principal Investigator

    R01MD016992     (CURRAN, GEOFFREY M)Sep 22, 2022 - May 31, 2025
    NIH/National Institutes of Health - Pass Through: University of North Carolina
    Addressing COVID-19 Vaccine Hesitancy in Rural Community Pharmacies: Reducing Disparities Through an Implementation Science Approach
    Role: Principal Investigator

    IK2HX003358     (HAYES, COREY)Apr 1, 2022 - Mar 31, 2027
    VA HSR&D
    Data to Clinical Action: Using Predictive Analytics to Improve Care of Veterans with Opioid Use Disorder
    Role: Co-Investigator

    CON     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator

    CON-80003534(GR114526)     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator

    CON-80004654(GR121975) Am 2     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator

    RM1DA055310     (PAINTER, JACOB T)Sep 30, 2021 - Jul 31, 2026
    NIH/Nat. Inst. on Drug Abuse - Pass Through: Yale University
    HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers
    Role: Principal Investigator

    1R37CA252113     (CURRAN, GEOFFREY M)Sep 1, 2021 - Aug 31, 2026
    NIH/Nat. Cancer Institute
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Principal Investigator

    1R37CA252113-01A1     (CURRAN, GEOFFREY M)Sep 1, 2021 - Aug 31, 2026
    NIH/Nat. Cancer Institute
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Principal Investigator

    5R37CA252113     (CURRAN, GEOFFREY M)Sep 1, 2021 - Aug 31, 2026
    NIH/Nat. Cancer Institute
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Principal Investigator

    5R37CA252113-02     (CURRAN, GEOFFREY M)Sep 1, 2021 - Aug 31, 2026
    NIH/Nat. Cancer Institute
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Principal Investigator

    5R37CA252113-04     (CURRAN, GEOFFREY M)Sep 1, 2021 - Aug 31, 2026
    NIH/Nat. Cancer Institute
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Principal Investigator

    5R37CA252113-05     (CURRAN, GEOFFREY M)Sep 1, 2021 - Aug 31, 2026
    NIH/Nat. Cancer Institute
    Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings
    Role: Principal Investigator

    P20GM109096     (STEWART, MARY K)Sep 1, 2021 - Jul 31, 2026
    NIH/Nat. Inst. of General Medical Sciences - Pass Through: Arkansas Children's Research Institute
    Center for Childhood Obesity Prevention (Community Engagement Core)
    Role: Principal Investigator

    UG3AT009765     (HUDSON, TERESA J)Sep 20, 2017 - Dec 31, 2019
    NIH/National Institutes of Health - Pass Through: Northern California Institute for Research and Education
    Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Functioning, and Quality of Life in Veterans
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Vordenberg SE, Fusco NM, Ward KE, Darley A, Brady JH, Culhane N, Habib MJ, Hernandez E, Moye PM, Munusamy S, Painter JT, Pope N, Stevenson TL, Vanderboll K, Chase PA, Matsumoto RR. An Integrative Review of Micro-credentials and Digital Badges for Pharmacy Educators. Am J Pharm Educ. 2024 Jan 23; 100660. PMID: 38272238.
      View in: PubMed
    2. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over one year of follow-up after initiating short-acting opioid formulations. Pain Med. 2024 Jan 18. PMID: 38243702.
      View in: PubMed
    3. Curran G, Mosley C, Gamble A, Painter J, Ounpraseuth S, Brewer NT, Teeter B, Smith M, Halladay J, Hughes T, Shepherd JG, Hastings T, Simpson K, Carpenter D. Addressing COVID-19 vaccine hesitancy in rural community pharmacies: a protocol for a stepped wedge randomized clinical trial. Implement Sci. 2023 Dec 18; 18(1):72. PMID: 38110979.
      View in: PubMed
    4. Painter JT, Raciborski RA, Matthieu MM, Oliver CM, Adkins DA, Garner KK. Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study. Eval Program Plann. 2023 Dec 14; 103:102398. PMID: 38183893.
      View in: PubMed
    5. Dhuliawala S, Payakachat N, Painter JT, Swindle T, Li C. Food Insecurity and Health Outcomes of Children With Intellectual and Developmental Disabilities in the United States. Am J Intellect Dev Disabil. 2023 11 01; 128(6):462-480. PMID: 37875275.
      View in: PubMed
    6. ElHassan NO, Crawford B, Alamarat Z, Painter JT. Clinical Review of Risk of Nephrotoxicity with Acyclovir Use for Treatment of Herpes Simplex Virus Infections in Neonates and Children. J Pediatr Pharmacol Ther. 2023; 28(6):490-503. PMID: 38130345.
      View in: PubMed
    7. Mahashabde R, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases. JCO Oncol Pract. 2023 Nov; 19(11):1009-1019. PMID: 37729600.
      View in: PubMed
    8. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619. PMID: 37328334.
      View in: PubMed
    9. Shah NK, Chandler MW, Cetto AV, Luciani LL, Painter J, Bailey D. Retrospective Cohort Study of Safety Outcomes Associated with Opioid Rotations to Buprenorphine. J Pain Palliat Care Pharmacother. 2023 Sep; 37(3):234-245. PMID: 37097772.
      View in: PubMed
    10. Matthieu MM, Ounpraseuth ST, Williams JS, Hu B, Adkins DA, Taylor LD, Oliver CM, Smith RM, Painter JT, McCullough JA, Garner KK. "Advancing" Advance Care Planning to Veterans in the Veterans Health Administration. Mil Med. 2023 03 20; 188(3-4):786-791. PMID: 35801841.
      View in: PubMed
    11. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 Mar 01; 39(3):107-118. PMID: 36728675.
      View in: PubMed
    12. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2023 Feb 08. PMID: 36753003.
      View in: PubMed
    13. Raciborski RA, Woodward EN, Painter JT. Economic analyses of behavioral health intervention implementation: Perspective on stakeholder engagement. Front Psychiatry. 2022; 13:1031325. PMID: 36620658.
      View in: PubMed
    14. Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227. PMID: 36688614.
      View in: PubMed
    15. Boehmer K, Lakkad M, Johnson C, Painter JT. Depression and diabetes distress in patients with diabetes. Prim Care Diabetes. 2023 02; 17(1):105-108. PMID: 36424309.
      View in: PubMed
    16. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data. J Cancer Surviv. 2023 08; 17(4):917-950. PMID: 36369622.
      View in: PubMed
    17. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957. PMID: 36000252.
      View in: PubMed
    18. Swindle T, Rutledge JM, Selig JP, Painter J, Zhang D, Martin J, Johnson SL, Whiteside-Mansell L, Almirall D, Barnett-McElwee T, Curran GM. Obesity prevention practices in early care and education settings: an adaptive implementation trial. Implement Sci. 2022 03 18; 17(1):25. PMID: 35303894.
      View in: PubMed
    19. Dare RK, Lusardi K, Pearson C, McCain KD, Daniels KB, Van S, Rico JC, Painter J, Lakkad M, Rosenbaum ER, Bariola JR. Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients. Clin Infect Dis. 2021 12 06; 73(11):e4616-e4626. PMID: 32463864.
      View in: PubMed
    20. Landes SJ, Jegley SM, Kirchner JE, Areno JP, Pitcock JA, Abraham TH, McBain SA, Singh RS, Bollinger MJ, Painter J, Woods JA, Curtis ND, Jones DE, Matarazzo BB, Reger MA, Comtois KA. Adapting Caring Contacts for Veterans in a Department of Veterans Affairs Emergency Department: Results From a Type 2 Hybrid Effectiveness-Implementation Pilot Study. Front Psychiatry. 2021; 12:746805. PMID: 34721114.
      View in: PubMed
    21. Callaway K, Lakkad M, Painter JT, Dayer L, Oswalt AK. The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients. J Pharm Pract. 2023 Apr; 36(2):276-280. PMID: 34376087.
      View in: PubMed
    22. Chopra D, Li C, Painter JT, Bona JP, Nookaew I, Martin BC. Characteristics and Network Influence of Providers Involved in the Treatment of Patients With Chronic Back, Neck or Joint Pain in Arkansas. J Pain. 2021 12; 22(12):1681-1695. PMID: 34174385.
      View in: PubMed
    23. Muzzio K, Chandler M, Painter JT, Dragic L. Characterizing Patients after Opioid Taper in a VA Medical Center. J Pain Palliat Care Pharmacother. 2021 Jun; 35(2):84-90. PMID: 33956566.
      View in: PubMed
    24. Klucher JM, Davis K, Lakkad M, Painter JT, Dare RK. Risk factors and clinical outcomes associated with blood culture contamination. Infect Control Hosp Epidemiol. 2022 03; 43(3):291-297. PMID: 33896442.
      View in: PubMed
    25. Dragic L, Webb T, Chandler M, Harrington SB, McDade E, Dayer L, Painter JT. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients. J Pain Palliat Care Pharmacother. 2020 Dec; 34(4):192-196. PMID: 32924715.
      View in: PubMed
    26. Matthieu MM, Ounpraseuth ST, Painter J, Waliski A, Williams JS, Hu B, Smith R, Garner KK. Evaluation of the national implementation of the VA Diffusion of Excellence Initiative on Advance Care Planning via Group Visits: protocol for a quality improvement evaluation. Implement Sci Commun. 2020; 1:19. PMID: 32885180.
      View in: PubMed
    27. Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):244-247. PMID: 31843373.
      View in: PubMed
    28. Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. J Emerg Med. 2019 11; 57(5):597-602. PMID: 31594747.
      View in: PubMed
    29. Stolarz AJ, Lakkad M, Klimberg VS, Painter JT. Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2019 Nov; 28(11):1809-1815. PMID: 31399477.
      View in: PubMed
    30. Chopra DA, Shah AB, Vadhariya AH, Painter JT. The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy. Epilepsy Behav. 2019 08; 97:169-173. PMID: 31252274.
      View in: PubMed
    31. Hammond DA, Painter JT, Meena N. Incidence of Clinically Significant Hypotension Stratified by Vasopressin Duration. J Intensive Care Med. 2019 Jan; 34(1):77-78. PMID: 30798676.
      View in: PubMed
    32. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339. PMID: 30572776.
      View in: PubMed
    33. Midboe AM, Martino S, Krein SL, Frank JW, Painter JT, Chandler M, Schroeder A, Fenton BT, Troszak L, Erhardt T, Kerns RD, Becker WC. Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol. Implement Sci. 2018 11 29; 13(1):145. PMID: 30486877.
      View in: PubMed
    34. Hammond DA, Rowe JM, Wiley TL, Painter JT. Evaluation of an elective course for preparing students to pursue postgraduate residency training. Curr Pharm Teach Learn. 2018 09; 10(9):1264-1271. PMID: 30497630.
      View in: PubMed
    35. Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock. Pharmacotherapy. 2018 05; 38(5):531-538. PMID: 29600824.
      View in: PubMed
    36. Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain Med. 2018 04 01; 19(4):774-787. PMID: 29036680.
      View in: PubMed
    37. Becker WC, Mattocks KM, Frank JW, Bair MJ, Jankowski RL, Kerns RD, Painter JT, Fenton BT, Midboe AM, Martino S. Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management. Addict Behav. 2018 11; 86:138-145. PMID: 29576479.
      View in: PubMed
    38. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 03; 159(3):451-459. PMID: 29189516.
      View in: PubMed
    39. Painter JT, Gressler L, Kathe N, Slabaugh SL, Blumenschein K. Consumer willingness to pay for pharmacy services: An updated review of the literature. Res Social Adm Pharm. 2018 12; 14(12):1091-1105. PMID: 29398405.
      View in: PubMed
    40. Hammond DA, James TB, Atkinson LN, Painter JT, Lusardi K. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients. Crit Care Nurse. 2018 Feb; 38(1):24-28. PMID: 29437075.
      View in: PubMed
    41. Gressler LE, Hammond DA, Painter JT. Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. J Pain Palliat Care Pharmacother. 2017 Sep - Dec; 31(3-4):228-236. PMID: 29336654.
      View in: PubMed
    42. Kathe N, Shah A, Said Q, Painter JT. DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study. Diabetes Ther. 2018 Feb; 9(1):141-151. PMID: 29236221.
      View in: PubMed
    43. Hammond DA, Chiu T, Painter JT, Meena N. Nonpharmacist Health Care Providers' Knowledge of and Opinions Regarding Medication Costs in Critically Ill Patients. Hosp Pharm. 2018 Jun; 53(3):188-193. PMID: 30147139.
      View in: PubMed
    44. Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock. J Intensive Care Med. 2019 Nov-Dec; 34(11-12):910-916. PMID: 28820036.
      View in: PubMed
    45. Hammond DA, Killingsworth CA, Painter JT, Pennick RE, Chatterjee K, Boye B, Meena N. Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults. Pharm Pract (Granada). 2017 Jul-Sep; 15(3):948. PMID: 28943978.
      View in: PubMed
    46. Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC. Comparative Effectiveness of Intra-Articular Hyaluronic Acid and Corticosteroid Injections on the Time to Surgical Knee Procedures. J Arthroplasty. 2017 12; 32(12):3591-3597.e24. PMID: 28781020.
      View in: PubMed
    47. Painter JT, Fortney JC, Austen MA, Pyne JM. Cost-Effectiveness of Telemedicine-Based Collaborative Care for Posttraumatic Stress Disorder. Psychiatr Serv. 2017 Nov 01; 68(11):1157-1163. PMID: 28669290.
      View in: PubMed
    48. Hammond DA, Atkinson LN, James TB, Painter JT, Lusardi K. Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients. Pharm Pract (Granada). 2017 Apr-Jun; 15(2):949. PMID: 28690700.
      View in: PubMed
    49. Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. J Intensive Care Med. 2019 Oct; 34(10):805-810. PMID: 28618919.
      View in: PubMed
    50. Hammond DA, Oyler DR, Devlin JW, Painter JT, Bolesta S, Swanson JM, Bailey BJ, Branan T, Barletta JF, Dunn B, Haney JS, Juang P, Kane-Gill SL, Kiser TH, Shafeeq H, Skaar D, Smithburger P, Taylor J. Perceived Motivating Factors and Barriers for the Completion of Postgraduate Training Among American Pharmacy Students Prior to Beginning Advanced Pharmacy Practice Experiences. Am J Pharm Educ. 2017 Jun; 81(5):90. PMID: 28720918.
      View in: PubMed
    51. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 06; 158(6):1039-1045. PMID: 28195856.
      View in: PubMed
    52. Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC. Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery. J Arthroplasty. 2017 10; 32(10):2952-2957.e21. PMID: 28606459.
      View in: PubMed
    53. Painter JT, Owen R, Henderson KL, Bauer MS, Mittal D, Hudson TJ. Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population. Pharmacotherapy. 2017 Apr; 37(4):438-446. PMID: 28164355.
      View in: PubMed
    54. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. J Opioid Manag. 2017 Mar/Apr; 13(2):95-103. PMID: 28829524.
      View in: PubMed
    55. Hammond DA, Vines CE, McPhee AL, Bhandari NR, Jones KM, Meena N, Painter JT. Effect of Etomidate on Pneumonia Development in Critically Ill, Nontrauma Patients. J Intensive Care Med. 2019 Jan; 34(1):34-39. PMID: 28027685.
      View in: PubMed
    56. Hammond DA, Hughes CA, Painter JT, Pennick RE, Chatterjee K, Boye B, Meena N. Impact of Targeted Educational Interventions on Clostridium difficile Infection Treatment in Critically Ill Adults. Hosp Pharm. 2016 Dec; 51(11):901-906. PMID: 28057949.
      View in: PubMed
    57. Drummond KL, Painter JT, Curran GM, Stanley R, Gifford AL, Rodriguez-Barradas M, Rimland D, Monson TP, Pyne JM. HIV patient and provider feedback on a telehealth collaborative care for depression intervention. AIDS Care. 2017 03; 29(3):290-298. PMID: 27871183.
      View in: PubMed
    58. Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study. Pharmacotherapy. 2016 05; 36(5):463-71. PMID: 26952639.
      View in: PubMed
    59. Brown JD, Hutchison LC, Li C, Painter JT, Martin BC. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States. J Am Geriatr Soc. 2016 Jan; 64(1):22-30. PMID: 26782849.
      View in: PubMed
    60. Painter JT, Fortney JC, Gifford AL, Rimland D, Monson T, Rodriguez-Barradas MC, Pyne JM. Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):377-85. PMID: 26102447.
      View in: PubMed
    61. Painter JT, Crofford LJ, Butler JS, Talbert J. Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome. Am J Pharm Benefits. 2014 Nov-Dec; 6(6):e177-e184. PMID: 28553437.
      View in: PubMed
    62. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. Am J Health Syst Pharm. 2014 Sep 15; 71(18):1539-54. PMID: 25174015.
      View in: PubMed
    63. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol. 2013 Mar; 19(2):72-7. PMID: 23364665.
      View in: PubMed
    64. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clin Ther. 2013 Mar; 35(3):303-11. PMID: 23485077.
      View in: PubMed
    65. Painter JT, Fink JL. Educational innovations: Categories of bulletin board postings designed to increase awareness of contemporary pharmaceutical policy issues. Pharm Pract (Granada). 2010 Oct; 8(4):255-9. PMID: 25126150.
      View in: PubMed
    Painter's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description